Revolution Medicines (FRA:42Z) Total Liabilities: €652.05 Mil (As of Mar. 2026)


FRA:42Z Revolution Medicines Inc FRA:42Z
30 GF Score
Price €167.00
GF Value €0.41
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Revolution Medicines Total Liabilities?

Revolution Medicines FRA:42Z -0.92% 30 Total Liabilities is €652.05 Mil as of Mar. 2026. GuruFocus rates FRA:42Z with a GF Score™ of 30/100 and a GF Value™ of €0.41 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Revolution Medicines's Total Liabilities for the quarter that ended in Mar. 2026 was €652.05 Mil.

Revolution Medicines's quarterly Total Liabilities increased from Sep. 2025 (€558.07 Mil) to Dec. 2025 (€617.62 Mil) and increased from Dec. 2025 (€617.62 Mil) to Mar. 2026 (€652.05 Mil).

Revolution Medicines's annual Total Liabilities increased from Dec. 2023 (€215.96 Mil) to Dec. 2024 (€279.91 Mil) and increased from Dec. 2024 (€279.91 Mil) to Dec. 2025 (€617.62 Mil).

Revolution Medicines Total Liabilities Historical Data

* Premium members only.

The historical data trend for Revolution Medicines's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Revolution Medicines Total Liabilities Chart

Revolution Medicines Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only 119.85 119.64 215.96 279.91 617.62

Revolution Medicines Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 265.66 489.16 558.07 617.62 652.05
FRA:42Z
30GF Score
Revolution Medicines Inc FRA:42Z
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Revolution Medicines Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Revolution Medicines's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=248.022+(121.468+246.123
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+2.009+0+0)
=617.62

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=2010.75-1393.128
=617.62

Revolution Medicines's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=250.503+(121.116+278.4
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+2.035+0+0)
=652.05

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=1949.483-1297.428
=652.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of €652.05 Mil mean?
Revolution Medicines (FRA:42Z) has a Total Liabilities of €652.05 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Revolution Medicines and its competitors.
Is Revolution Medicines' Total Liabilities too high?
Revolution Medicines' current Total Liabilities is €652.05 Mil. Overall, Revolution Medicines has a GF Score™ of 30/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Revolution Medicines' Total Liabilities compare to ALNY and ONC?
Revolution Medicines' Total Liabilities of €652.05 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Revolution Medicines and its competitors. Revolution Medicines's current Total Liabilities is €652.05 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Revolution Medicines stock overvalued right now?
Based on GuruFocus' analysis, Revolution Medicines (FRA:42Z) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.41, compared to a current price of €167.00 — trading 40631.7% above its estimated fair value. The current Total Liabilities is €652.05 Mil. Revolution Medicines' overall GF Score™ is 30/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Revolution Medicines (FRA:42Z), the current Total Liabilities is €652.05 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Revolution Medicines (FRA:42Z) Overvalued in 2026?

Based on GuruFocus' analysis, Revolution Medicines stock appears to be overvalued. The current stock price of €167.00 is trading 40631.7% above its estimated GF Value™ of €0.41. GuruFocus considers Revolution Medicines to be Significantly Overvalued.

Key valuation signals for FRA:42Z:

  • Total Liabilities: €652.05 Mil
  • GF Value™: €0.41 vs. price of €167.00 (40631.7% above fair value)
  • GF Score™: 30/100 with 4 warning signs

No single metric tells the full story. See the FRA:42Z stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Revolution Medicines Business Description

Address 700 Saginaw Drive, Redwood City, CA, USA, 94063
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.
30GF Score

Get the complete analysis for FRA:42Z

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€167.00
Price
€0.41
GF Value